EP4003401A4
(en )
2023-08-16
Compositions and methods comprising protease-activated therapeutic agents
EP4175949A4
(en )
2024-02-28
Methods and compositions for targeting tregs using ccr8 inhibitors
EP4090752A4
(en )
2023-08-30
Plakophillin-2 gene therapy methods and compositions
EP4110358A4
(en )
2024-04-17
Placental tissue compositions and methods
AU2023901743A0
(en )
2023-06-22
Cell line 2 selected for therapeutic efficacy and related compositions and methods
AU2023901744A0
(en )
2023-06-22
Cell line 3 selected for therapeutic efficacy and related compositions and methods
AU2022901507A0
(en )
2022-06-16
Cell line 2 selected for therapeutic efficacy and related compositions and methods
AU2022901509A0
(en )
2022-06-16
Cell line 3 selected for therapeutic efficacy and related compositions and methods
EP4114176A4
(en )
2024-04-17
Sterilization compositions and methods for using thereof
AU2021901727A0
(en )
2021-06-24
Cell line 2 selected for therapeutic efficacy and related compositions and methods
AU2021901728A0
(en )
2021-06-24
Cell line 3 selected for therapeutic efficacy and related compositions and methods
AU2024901664A0
(en )
2024-06-13
Cell line 3 selected for therapeutic efficacy and related compositions and methods
AU2024901663A0
(en )
2024-06-13
Cell line 2 selected for therapeutic efficacy and related compositions and methods
AU2023901742A0
(en )
2023-06-22
Cell line selected for therapeutic efficacy and related compositions and methods
AU2022901506A0
(en )
2022-06-16
Cell line selected for therapeutic efficacy and related compositions and methods
AU2024901662A0
(en )
2024-06-13
Cell line selected for therapeutic efficacy and related compositions and methods
AU2021901726A0
(en )
2021-06-24
Cell line selected for therapeutic efficacy and related compositions and methods
EP4175978A4
(en )
2024-06-26
Compositions and methods for treating crp-mediated diseases
EP4136072A4
(en )
2024-05-22
Compositions and methods for treating pain and/or inflammation
AU2023901412A0
(en )
2023-05-25
Therapeutic Agents and Compositions and Related Methods
AU2024900070A0
(en )
2024-01-25
Therapeutic methods and related compositions
EP3941453A4
(en )
2022-12-28
Therapeutic methods and compositions for treating lymphoma using 6,8-bis-benzylthio-octanoic acid
AU2024900581A0
(en )
2024-03-14
Therapeutic And Prophylactic Agents and Related Compositions And Methods
AU2022900368A0
(en )
2022-03-03
Compositions and Methods for Modulating Inflammation 2
AU2022900370A0
(en )
2022-03-03
Compositions and Methods for Modulating Inflammation 3